Neuropace Stock Price History
NPCE Stock | USD 10.69 0.26 2.49% |
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neuropace stands at 10.69, as last reported on the 17th of March 2025, with the highest price reaching 10.82 and the lowest price hitting 10.43 during the day. Neuropace has Sharpe Ratio of -0.0112, which conveys that the firm had a -0.0112 % return per unit of risk over the last 3 months. Neuropace exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuropace's Standard Deviation of 3.96, mean deviation of 3.18, and Risk Adjusted Performance of 0.0069 to check out the risk estimate we provide.
At present, Neuropace's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, Neuropace's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 42.71, whereas Price Earnings Ratio is forecasted to decline to (12.61). Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neuropace |
Sharpe Ratio = -0.0112
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NPCE |
Estimated Market Risk
4.02 actual daily | 35 65% of assets are more volatile |
Expected Return
-0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neuropace is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuropace by adding Neuropace to a well-diversified portfolio.
Price Book 43.6268 | Enterprise Value Ebitda (16.94) | Price Sales 4.356 | Shares Float 21.1 M | Wall Street Target Price 17.5714 |
Neuropace Stock Price History Chart
There are several ways to analyze Neuropace Stock price data. The simplest method is using a basic Neuropace candlestick price chart, which shows Neuropace price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 24, 2025 | 14.69 |
Lowest Price | March 10, 2025 | 10.04 |
Neuropace March 17, 2025 Stock Price Synopsis
Various analyses of Neuropace's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neuropace Stock. It can be used to describe the percentage change in the price of Neuropace from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neuropace Stock.Neuropace Price Rate Of Daily Change | 1.02 | |
Neuropace Price Action Indicator | 0.19 | |
Neuropace Price Daily Balance Of Power | 0.67 |
Neuropace March 17, 2025 Stock Price Analysis
Neuropace Stock Price History Data
The price series of Neuropace for the period between Tue, Dec 17, 2024 and Mon, Mar 17, 2025 has a statistical range of 4.65 with a coefficient of variation of 10.21. The daily prices for the period are spread out with arithmetic mean of 12.26. The median price for the last 90 days is 11.97.Open | High | Low | Close | Volume | ||
03/17/2025 | 10.43 | 10.82 | 10.43 | 10.69 | ||
03/17/2025 | 10.43 | 10.82 | 10.43 | 10.69 | ||
03/14/2025 | 10.69 | 10.82 | 10.49 | 10.69 | 97,761 | |
03/13/2025 | 10.95 | 11.01 | 10.19 | 10.43 | 151,111 | |
03/12/2025 | 10.35 | 11.09 | 10.24 | 10.97 | 194,441 | |
03/11/2025 | 10.06 | 10.42 | 9.56 | 10.36 | 221,011 | |
03/10/2025 | 10.68 | 10.96 | 9.91 | 10.04 | 216,875 | |
03/07/2025 | 11.09 | 11.21 | 10.53 | 11.00 | 271,316 | |
03/06/2025 | 11.47 | 11.63 | 10.55 | 11.18 | 237,350 | |
03/05/2025 | 12.65 | 12.97 | 10.52 | 11.63 | 434,749 | |
03/04/2025 | 11.62 | 12.22 | 11.10 | 11.92 | 245,581 | |
03/03/2025 | 12.85 | 12.87 | 11.71 | 11.81 | 546,203 | |
02/28/2025 | 12.51 | 13.10 | 12.30 | 12.95 | 134,520 | |
02/27/2025 | 13.53 | 13.64 | 12.32 | 12.56 | 149,570 | |
02/26/2025 | 13.61 | 13.97 | 13.26 | 13.48 | 250,181 | |
02/25/2025 | 13.41 | 13.97 | 13.32 | 13.84 | 213,369 | |
02/24/2025 | 13.79 | 14.16 | 13.46 | 13.52 | 221,410 | |
02/21/2025 | 14.20 | 14.21 | 13.25 | 13.77 | 532,543 | |
02/20/2025 | 13.44 | 14.39 | 13.06 | 14.23 | 455,934 | |
02/19/2025 | 13.25 | 13.74 | 12.90 | 13.45 | 321,309 | |
02/18/2025 | 13.11 | 13.47 | 12.36 | 13.44 | 254,117 | |
02/14/2025 | 10.31 | 13.65 | 10.30 | 12.31 | 1,959,813 | |
02/13/2025 | 12.20 | 12.20 | 11.62 | 12.09 | 103,743 | |
02/12/2025 | 12.08 | 12.58 | 11.68 | 12.09 | 77,451 | |
02/11/2025 | 12.35 | 12.65 | 12.05 | 12.30 | 89,892 | |
02/10/2025 | 12.82 | 12.84 | 12.02 | 12.52 | 152,182 | |
02/07/2025 | 13.53 | 13.68 | 12.50 | 13.12 | 133,793 | |
02/06/2025 | 14.36 | 14.40 | 13.53 | 13.66 | 366,673 | |
02/05/2025 | 13.91 | 14.40 | 13.72 | 14.29 | 114,376 | |
02/04/2025 | 13.52 | 14.01 | 13.27 | 13.90 | 157,940 | |
02/03/2025 | 13.64 | 14.00 | 13.21 | 13.61 | 154,505 | |
01/31/2025 | 14.14 | 14.27 | 13.50 | 13.76 | 163,085 | |
01/30/2025 | 14.99 | 15.04 | 13.55 | 14.19 | 462,937 | |
01/29/2025 | 14.42 | 15.00 | 14.15 | 14.69 | 319,875 | |
01/28/2025 | 14.18 | 14.95 | 13.77 | 14.13 | 99,683 | |
01/27/2025 | 14.42 | 15.02 | 13.90 | 14.24 | 222,929 | |
01/24/2025 | 14.02 | 15.11 | 13.69 | 14.69 | 153,619 | |
01/23/2025 | 14.01 | 14.19 | 13.14 | 14.02 | 186,311 | |
01/22/2025 | 14.00 | 14.41 | 13.33 | 14.04 | 359,080 | |
01/21/2025 | 13.77 | 13.77 | 12.25 | 13.06 | 258,490 | |
01/17/2025 | 12.03 | 12.09 | 11.75 | 11.97 | 83,546 | |
01/16/2025 | 12.05 | 12.22 | 11.37 | 11.91 | 110,352 | |
01/15/2025 | 12.26 | 12.41 | 11.75 | 12.00 | 101,494 | |
01/14/2025 | 12.32 | 12.65 | 11.75 | 11.84 | 79,587 | |
01/13/2025 | 12.00 | 12.60 | 11.85 | 12.11 | 167,093 | |
01/10/2025 | 13.65 | 13.65 | 11.18 | 11.94 | 284,614 | |
01/08/2025 | 12.41 | 12.50 | 11.75 | 12.01 | 69,884 | |
01/07/2025 | 11.95 | 12.49 | 11.41 | 12.42 | 61,151 | |
01/06/2025 | 11.65 | 12.53 | 11.52 | 11.93 | 92,595 | |
01/03/2025 | 11.57 | 12.46 | 11.27 | 11.57 | 41,880 | |
01/02/2025 | 11.36 | 11.66 | 11.12 | 11.58 | 37,134 | |
12/31/2024 | 11.02 | 11.45 | 10.43 | 11.19 | 58,497 | |
12/30/2024 | 10.65 | 11.07 | 10.44 | 10.87 | 45,067 | |
12/27/2024 | 11.23 | 11.62 | 10.36 | 10.67 | 48,541 | |
12/26/2024 | 11.06 | 11.39 | 10.95 | 11.35 | 56,613 | |
12/24/2024 | 11.35 | 11.44 | 11.10 | 11.14 | 26,277 | |
12/23/2024 | 11.47 | 11.90 | 11.08 | 11.44 | 44,113 | |
12/20/2024 | 11.00 | 11.59 | 10.76 | 11.53 | 188,294 | |
12/19/2024 | 11.01 | 11.66 | 10.76 | 11.14 | 55,500 | |
12/18/2024 | 11.69 | 12.23 | 9.92 | 10.64 | 86,205 | |
12/17/2024 | 11.59 | 12.41 | 11.30 | 11.52 | 103,674 |
About Neuropace Stock history
Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 29.1 M | 27.8 M | |
Net Loss | -42.4 M | -44.5 M |
Neuropace Quarterly Net Working Capital |
|
Neuropace Stock Technical Analysis
Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
Neuropace Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0069 | |||
Jensen Alpha | 0.1321 | |||
Total Risk Alpha | 0.4823 | |||
Treynor Ratio | (0.01) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |